Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.71030488 |
2 | L-phenylalanine catabolic process (GO:0006559) | 7.71030488 |
3 | L-phenylalanine metabolic process (GO:0006558) | 7.39680780 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.39680780 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 6.91676329 |
6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.51931387 |
7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.51931387 |
8 | modulation by symbiont of host immune response (GO:0052553) | 6.51931387 |
9 | positive regulation by symbiont of host defense response (GO:0052509) | 6.51931387 |
10 | modulation by symbiont of host defense response (GO:0052031) | 6.51931387 |
11 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.51931387 |
12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.45401722 |
13 | negative regulation of cell killing (GO:0031342) | 6.45401722 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.38812657 |
15 | indole-containing compound catabolic process (GO:0042436) | 6.20888637 |
16 | indolalkylamine catabolic process (GO:0046218) | 6.20888637 |
17 | tryptophan catabolic process (GO:0006569) | 6.20888637 |
18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.15678264 |
19 | kynurenine metabolic process (GO:0070189) | 6.12356907 |
20 | urea metabolic process (GO:0019627) | 5.86882910 |
21 | urea cycle (GO:0000050) | 5.86882910 |
22 | bile acid biosynthetic process (GO:0006699) | 5.85150952 |
23 | tryptophan metabolic process (GO:0006568) | 5.82070203 |
24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.74096698 |
25 | sulfur amino acid catabolic process (GO:0000098) | 5.54850977 |
26 | high-density lipoprotein particle remodeling (GO:0034375) | 5.52796054 |
27 | glyoxylate metabolic process (GO:0046487) | 5.52173718 |
28 | serine family amino acid catabolic process (GO:0009071) | 5.49401459 |
29 | detection of other organism (GO:0098543) | 5.47049091 |
30 | macrophage activation involved in immune response (GO:0002281) | 5.45637963 |
31 | nitrogen cycle metabolic process (GO:0071941) | 5.39084416 |
32 | neutrophil activation involved in immune response (GO:0002283) | 5.35327499 |
33 | negative regulation of fibrinolysis (GO:0051918) | 5.34615228 |
34 | alpha-linolenic acid metabolic process (GO:0036109) | 5.34537384 |
35 | detection of molecule of bacterial origin (GO:0032490) | 5.32432170 |
36 | cysteine metabolic process (GO:0006534) | 5.29028065 |
37 | regulation of fibrinolysis (GO:0051917) | 5.15342487 |
38 | bile acid metabolic process (GO:0008206) | 5.14890060 |
39 | protein carboxylation (GO:0018214) | 5.09071316 |
40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.09071316 |
41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.08999814 |
42 | detection of bacterium (GO:0016045) | 5.06673312 |
43 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.05430398 |
44 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.01665456 |
45 | aromatic amino acid family metabolic process (GO:0009072) | 5.00886022 |
46 | homocysteine metabolic process (GO:0050667) | 5.00388531 |
47 | response to peptidoglycan (GO:0032494) | 4.95197247 |
48 | detection of external biotic stimulus (GO:0098581) | 4.94266423 |
49 | complement activation, alternative pathway (GO:0006957) | 4.93975591 |
50 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.93404763 |
51 | regulation of protein activation cascade (GO:2000257) | 4.90000659 |
52 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.89340853 |
53 | alpha-amino acid catabolic process (GO:1901606) | 4.85831128 |
54 | tyrosine metabolic process (GO:0006570) | 4.83845925 |
55 | cellular extravasation (GO:0045123) | 4.82646406 |
56 | glycine metabolic process (GO:0006544) | 4.69860928 |
57 | negative regulation of cholesterol transport (GO:0032375) | 4.69717599 |
58 | negative regulation of sterol transport (GO:0032372) | 4.69717599 |
59 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.69543011 |
60 | amino-acid betaine metabolic process (GO:0006577) | 4.69456857 |
61 | reverse cholesterol transport (GO:0043691) | 4.68486867 |
62 | regulation of cholesterol esterification (GO:0010872) | 4.68285918 |
63 | leukocyte aggregation (GO:0070486) | 4.67503739 |
64 | regulation of triglyceride catabolic process (GO:0010896) | 4.64563565 |
65 | lysine catabolic process (GO:0006554) | 4.63442848 |
66 | lysine metabolic process (GO:0006553) | 4.63442848 |
67 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.61990514 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 4.61206353 |
69 | protein-lipid complex remodeling (GO:0034368) | 4.61046180 |
70 | macromolecular complex remodeling (GO:0034367) | 4.61046180 |
71 | plasma lipoprotein particle remodeling (GO:0034369) | 4.61046180 |
72 | coenzyme catabolic process (GO:0009109) | 4.58615828 |
73 | triglyceride homeostasis (GO:0070328) | 4.57969745 |
74 | acylglycerol homeostasis (GO:0055090) | 4.57969745 |
75 | microglial cell activation (GO:0001774) | 4.55413743 |
76 | regulation of complement activation (GO:0030449) | 4.54806186 |
77 | glutamate metabolic process (GO:0006536) | 4.54343174 |
78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.53114404 |
79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.50573545 |
80 | cellular amino acid catabolic process (GO:0009063) | 4.48606746 |
81 | response to host immune response (GO:0052572) | 4.47631705 |
82 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.47631705 |
83 | negative regulation of interleukin-12 production (GO:0032695) | 4.44781260 |
84 | drug catabolic process (GO:0042737) | 4.40599932 |
85 | neutrophil activation (GO:0042119) | 4.39846357 |
86 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.38161672 |
87 | respiratory burst (GO:0045730) | 4.36662877 |
88 | serine family amino acid metabolic process (GO:0009069) | 4.36656953 |
89 | indolalkylamine metabolic process (GO:0006586) | 4.36316747 |
90 | detection of biotic stimulus (GO:0009595) | 4.35380371 |
91 | cellular modified amino acid catabolic process (GO:0042219) | 4.31731115 |
92 | bile acid and bile salt transport (GO:0015721) | 4.31226618 |
93 | phospholipid efflux (GO:0033700) | 4.30927657 |
94 | regulation of gamma-delta T cell activation (GO:0046643) | 4.23384135 |
95 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22182632 |
96 | cellular biogenic amine catabolic process (GO:0042402) | 4.21295154 |
97 | amine catabolic process (GO:0009310) | 4.21295154 |
98 | macrophage activation (GO:0042116) | 4.17700223 |
99 | cellular ketone body metabolic process (GO:0046950) | 4.17381965 |
100 | response to interleukin-15 (GO:0070672) | 4.16474457 |
101 | benzene-containing compound metabolic process (GO:0042537) | 4.16165691 |
102 | serine family amino acid biosynthetic process (GO:0009070) | 4.15113806 |
103 | neutrophil mediated immunity (GO:0002446) | 4.11031036 |
104 | cellular glucuronidation (GO:0052695) | 4.10277271 |
105 | response to host (GO:0075136) | 4.08685855 |
106 | response to host defenses (GO:0052200) | 4.08685855 |
107 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.08685855 |
108 | plasma lipoprotein particle clearance (GO:0034381) | 4.07985389 |
109 | cholesterol efflux (GO:0033344) | 4.07478378 |
110 | regulation of bile acid biosynthetic process (GO:0070857) | 3.95748380 |
111 | exogenous drug catabolic process (GO:0042738) | 3.94499134 |
112 | arginine metabolic process (GO:0006525) | 3.94180032 |
113 | myeloid cell activation involved in immune response (GO:0002275) | 3.92936183 |
114 | granulocyte activation (GO:0036230) | 3.92581975 |
115 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.92152466 |
116 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.84857926 |
117 | cellular response to interleukin-15 (GO:0071350) | 3.80420536 |
118 | low-density lipoprotein particle remodeling (GO:0034374) | 3.79698119 |
119 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.79617185 |
120 | organic acid catabolic process (GO:0016054) | 3.78041852 |
121 | carboxylic acid catabolic process (GO:0046395) | 3.78041852 |
122 | negative regulation of T cell mediated immunity (GO:0002710) | 3.77461223 |
123 | regulation of mast cell degranulation (GO:0043304) | 3.76498576 |
124 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.75316554 |
125 | ethanol oxidation (GO:0006069) | 3.75208889 |
126 | cofactor catabolic process (GO:0051187) | 3.74530361 |
127 | aspartate family amino acid catabolic process (GO:0009068) | 3.73843260 |
128 | regulation of cholesterol homeostasis (GO:2000188) | 3.69765220 |
129 | plasma lipoprotein particle assembly (GO:0034377) | 3.69625276 |
130 | short-chain fatty acid metabolic process (GO:0046459) | 3.67744098 |
131 | drug metabolic process (GO:0017144) | 3.67409918 |
132 | immunoglobulin mediated immune response (GO:0016064) | 3.67341779 |
133 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.64797480 |
134 | negative regulation of lipase activity (GO:0060192) | 3.63458377 |
135 | aldehyde catabolic process (GO:0046185) | 3.62731113 |
136 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62594055 |
137 | intestinal cholesterol absorption (GO:0030299) | 3.61875347 |
138 | positive regulation of mast cell activation (GO:0033005) | 3.61029051 |
139 | positive regulation of lipid catabolic process (GO:0050996) | 3.60296673 |
140 | fibrinolysis (GO:0042730) | 3.60216471 |
141 | ketone body metabolic process (GO:1902224) | 3.59692444 |
142 | cholesterol homeostasis (GO:0042632) | 3.59662541 |
143 | NAD biosynthetic process (GO:0009435) | 3.57022588 |
144 | myeloid leukocyte mediated immunity (GO:0002444) | 3.56688336 |
145 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.55694194 |
146 | acetyl-CoA metabolic process (GO:0006084) | 3.55286943 |
147 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.54234726 |
148 | flavonoid metabolic process (GO:0009812) | 3.53849854 |
149 | sterol homeostasis (GO:0055092) | 3.53835398 |
150 | glucuronate metabolic process (GO:0019585) | 3.53727485 |
151 | uronic acid metabolic process (GO:0006063) | 3.53727485 |
152 | epoxygenase P450 pathway (GO:0019373) | 3.53184331 |
153 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.50970567 |
154 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.50970567 |
155 | cytolysis (GO:0019835) | 3.50146004 |
156 | phospholipid homeostasis (GO:0055091) | 3.49884171 |
157 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.49560690 |
158 | blood coagulation, intrinsic pathway (GO:0007597) | 3.48572754 |
159 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44300048 |
160 | B cell receptor signaling pathway (GO:0050853) | 3.41807561 |
161 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.37834343 |
162 | type I interferon signaling pathway (GO:0060337) | 3.37392178 |
163 | cellular response to type I interferon (GO:0071357) | 3.37392178 |
164 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.36649997 |
165 | leukocyte degranulation (GO:0043299) | 3.35249247 |
166 | regulation of mast cell activation (GO:0033003) | 3.34385044 |
167 | response to type I interferon (GO:0034340) | 3.33824809 |
168 | regulation of leukocyte degranulation (GO:0043300) | 3.32053173 |
169 | response to muramyl dipeptide (GO:0032495) | 3.24155389 |
170 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.22679759 |
171 | germinal center formation (GO:0002467) | 3.21746613 |
172 | regulation of regulated secretory pathway (GO:1903305) | 3.12841682 |
173 | defense response to protozoan (GO:0042832) | 3.12770255 |
174 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.11658459 |
175 | negative regulation of type 2 immune response (GO:0002829) | 3.07879177 |
176 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.05226602 |
177 | positive regulation of mast cell degranulation (GO:0043306) | 3.05226602 |
178 | regulation of tolerance induction (GO:0002643) | 3.04896222 |
179 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03769654 |
180 | regulation of B cell differentiation (GO:0045577) | 3.02751304 |
181 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.02253747 |
182 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00782046 |
183 | dendritic cell migration (GO:0036336) | 3.00170893 |
184 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.99598220 |
185 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.99598220 |
186 | neutrophil chemotaxis (GO:0030593) | 2.99566115 |
187 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99023464 |
188 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.97181514 |
189 | negative regulation of B cell mediated immunity (GO:0002713) | 2.97181514 |
190 | myeloid leukocyte activation (GO:0002274) | 2.97120277 |
191 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.96797079 |
192 | positive regulation of interferon-alpha production (GO:0032727) | 2.96564946 |
193 | regulation of T cell tolerance induction (GO:0002664) | 2.94215948 |
194 | neutrophil migration (GO:1990266) | 2.91721733 |
195 | negative regulation of phagocytosis (GO:0050765) | 2.90747337 |
196 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.89208511 |
197 | negative regulation of interleukin-6 production (GO:0032715) | 2.88018686 |
198 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.87118103 |
199 | dendritic cell chemotaxis (GO:0002407) | 2.86819211 |
200 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.86459760 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.08183806 |
2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.88575661 |
3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.52433195 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.22887107 |
5 | * FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.15813430 |
6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.95457219 |
7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.75788718 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.70853791 |
9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.16800025 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.89048851 |
11 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.87438432 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.68926419 |
13 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.66806276 |
14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.61850951 |
15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.20911534 |
16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.18624957 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.18385309 |
18 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.76947766 |
19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73756375 |
20 | SPI1_23127762_ChIP-Seq_K562_Human | 2.72297015 |
21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.70126957 |
22 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.60205172 |
23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.60148601 |
24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.55595544 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.55489116 |
26 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.48854213 |
27 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.47034435 |
28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.34372914 |
29 | MAF_26560356_Chip-Seq_TH1_Human | 2.23237962 |
30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.21197041 |
31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20558257 |
32 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.18388141 |
33 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.14184598 |
34 | MYB_26560356_Chip-Seq_TH2_Human | 2.14063632 |
35 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.11236387 |
36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.10903910 |
37 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.05509339 |
38 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03014142 |
39 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3743131 |
40 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98685571 |
41 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.98301340 |
42 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95592574 |
43 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.91589733 |
44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.91326319 |
45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.90248527 |
46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.86131068 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86044214 |
48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.83782525 |
49 | MYB_26560356_Chip-Seq_TH1_Human | 1.83607039 |
50 | MYC_22102868_ChIP-Seq_BL_Human | 1.74222939 |
51 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.72570329 |
52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71979669 |
53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.65924425 |
54 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.64329376 |
55 | MAF_26560356_Chip-Seq_TH2_Human | 1.62219843 |
56 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60501147 |
57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59458612 |
58 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57109231 |
59 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.55976497 |
60 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53892197 |
61 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53787097 |
62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53168214 |
63 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.52278038 |
64 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.50360591 |
65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.49901361 |
66 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.49173254 |
67 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.49034316 |
68 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.48902572 |
69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44499944 |
70 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.44465328 |
71 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.40721877 |
72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39300488 |
73 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.39011120 |
74 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38377349 |
75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.37348203 |
76 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35377268 |
77 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35310668 |
78 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32674050 |
79 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.31427464 |
80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29787721 |
81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29741577 |
82 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26882316 |
83 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26028652 |
84 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25369469 |
85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25344504 |
86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23037522 |
87 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.22459126 |
88 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.22442675 |
89 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22243009 |
90 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19209506 |
91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18874518 |
92 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16918020 |
93 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16790690 |
94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16707461 |
95 | GATA1_19941826_ChIP-Seq_K562_Human | 1.16446413 |
96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15435346 |
97 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14843865 |
98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12306618 |
99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12153701 |
100 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.07985969 |
101 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.07634555 |
102 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06211394 |
103 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04682433 |
104 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04623503 |
105 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01023732 |
106 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.00447613 |
107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.00340331 |
108 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00014611 |
109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99570917 |
110 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.99090885 |
111 | * RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98499072 |
112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97063941 |
113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.96330279 |
114 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.92982975 |
115 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92491363 |
116 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.91429305 |
117 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91091870 |
118 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.90941703 |
119 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.88755328 |
120 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88734237 |
121 | KDM2B_26808549_Chip-Seq_K562_Human | 0.88352490 |
122 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.87867265 |
123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.87834383 |
124 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.86710570 |
125 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85251427 |
126 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.84065146 |
127 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.83969886 |
128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.82486274 |
129 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82234425 |
130 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.81680914 |
131 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81245670 |
132 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80495913 |
133 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80194258 |
134 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.77534712 |
135 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.77289755 |
136 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.76323338 |
137 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.73724537 |
138 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.72259773 |
139 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 0.70853668 |
140 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.69726951 |
141 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.68229385 |
142 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.67641976 |
143 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.67416020 |
144 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.66435503 |
145 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.66297792 |
146 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.65699720 |
147 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.65272251 |
148 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.65182568 |
149 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.64288723 |
150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.63910153 |
151 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.63675482 |
152 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.62814820 |
153 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.62419871 |
154 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.61558633 |
155 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.60781884 |
156 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.60443092 |
157 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58986863 |
158 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.58775245 |
159 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.58701924 |
160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58192694 |
161 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.57443617 |
162 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.57285565 |
163 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.56895651 |
164 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.55710367 |
165 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.55049875 |
166 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.53403404 |
167 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.53337853 |
168 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.53300347 |
169 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.52508357 |
170 | * SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.52410349 |
171 | SOX2_22085726_ChIP-Seq_NPCs_Mouse | 0.51881002 |
172 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.50191669 |
173 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.49922991 |
174 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.49766009 |
175 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.49766009 |
176 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.49766009 |
177 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.49703691 |
178 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48916307 |
179 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.47940768 |
180 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.47618343 |
181 | CBP_21632823_ChIP-Seq_H3396_Human | 0.46880236 |
182 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.46607746 |
183 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46561424 |
184 | GATA1_22025678_ChIP-Seq_K562_Human | 0.46428526 |
185 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.45672903 |
186 | NCOR_22424771_ChIP-Seq_293T_Human | 0.45478599 |
187 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.45315176 |
188 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.44557090 |
189 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.44067982 |
190 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.43873660 |
191 | * KLF4_19829295_ChIP-Seq_ESCs_Human | 0.43656588 |
192 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.43328192 |
193 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.43252723 |
194 | GATA3_21867929_ChIP-Seq_CD8_Mouse | 0.43218455 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 8.29324147 |
2 | MP0005360_urolithiasis | 7.42546033 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.64854325 |
4 | MP0005365_abnormal_bile_salt | 6.25769155 |
5 | MP0003724_increased_susceptibility_to | 5.55808282 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 5.36615703 |
7 | MP0003806_abnormal_nucleotide_metabolis | 4.44068029 |
8 | MP0003436_decreased_susceptibility_to | 4.27261863 |
9 | MP0003303_peritoneal_inflammation | 4.00961041 |
10 | MP0003252_abnormal_bile_duct | 3.78228724 |
11 | MP0001835_abnormal_antigen_presentation | 3.65510679 |
12 | MP0010329_abnormal_lipoprotein_level | 3.50373969 |
13 | MP0002419_abnormal_innate_immunity | 3.26212650 |
14 | MP0005083_abnormal_biliary_tract | 2.98265712 |
15 | MP0005025_abnormal_response_to | 2.89923212 |
16 | MP0009785_altered_susceptibility_to | 2.86716857 |
17 | MP0009840_abnormal_foam_cell | 2.84732880 |
18 | MP0003195_calcinosis | 2.84332509 |
19 | MP0001800_abnormal_humoral_immune | 2.83864203 |
20 | MP0005332_abnormal_amino_acid | 2.79271265 |
21 | MP0000685_abnormal_immune_system | 2.74573116 |
22 | MP0005000_abnormal_immune_tolerance | 2.72807357 |
23 | MP0005671_abnormal_response_to | 2.69622967 |
24 | MP0001790_abnormal_immune_system | 2.64042807 |
25 | MP0005387_immune_system_phenotype | 2.64042807 |
26 | MP0001666_abnormal_nutrient_absorption | 2.56044818 |
27 | MP0002723_abnormal_immune_serum | 2.55451669 |
28 | MP0006082_CNS_inflammation | 2.50888690 |
29 | MP0008260_abnormal_autophagy | 2.48819254 |
30 | MP0002420_abnormal_adaptive_immunity | 2.48307015 |
31 | MP0001819_abnormal_immune_cell | 2.45506435 |
32 | MP0002452_abnormal_antigen_presenting | 2.41185592 |
33 | MP0004019_abnormal_vitamin_homeostasis | 2.23162413 |
34 | MP0003300_gastrointestinal_ulcer | 2.18092461 |
35 | MP0002132_abnormal_respiratory_system | 2.16902989 |
36 | MP0001533_abnormal_skeleton_physiology | 2.15136601 |
37 | MP0003868_abnormal_feces_composition | 2.06512920 |
38 | MP0002118_abnormal_lipid_homeostasis | 2.05070395 |
39 | MP0002148_abnormal_hypersensitivity_rea | 2.01523533 |
40 | MP0000609_abnormal_liver_physiology | 2.00347392 |
41 | MP0005464_abnormal_platelet_physiology | 1.99312724 |
42 | MP0003828_pulmonary_edema | 1.91128932 |
43 | MP0002405_respiratory_system_inflammati | 1.90546788 |
44 | MP0003172_abnormal_lysosome_physiology | 1.87618163 |
45 | MP0002398_abnormal_bone_marrow | 1.83982068 |
46 | MP0000716_abnormal_immune_system | 1.81765096 |
47 | MP0003191_abnormal_cellular_cholesterol | 1.80671402 |
48 | MP0001764_abnormal_homeostasis | 1.77375978 |
49 | MP0003763_abnormal_thymus_physiology | 1.76175342 |
50 | MP0005319_abnormal_enzyme/_coenzyme | 1.72920991 |
51 | MP0001845_abnormal_inflammatory_respons | 1.68089075 |
52 | MP0009278_abnormal_bone_marrow | 1.66041839 |
53 | MP0003183_abnormal_peptide_metabolism | 1.64899247 |
54 | MP0002138_abnormal_hepatobiliary_system | 1.58536109 |
55 | MP0002277_abnormal_respiratory_mucosa | 1.56507537 |
56 | MP0004947_skin_inflammation | 1.52899936 |
57 | MP0004883_abnormal_blood_vessel | 1.52767011 |
58 | MP0010155_abnormal_intestine_physiology | 1.52471348 |
59 | MP0003866_abnormal_defecation | 1.50304850 |
60 | MP0004381_abnormal_hair_follicle | 1.49473317 |
61 | MP0002722_abnormal_immune_system | 1.49315739 |
62 | MP0000689_abnormal_spleen_morphology | 1.48179811 |
63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.46191343 |
64 | MP0000465_gastrointestinal_hemorrhage | 1.46040257 |
65 | MP0005410_abnormal_fertilization | 1.45273029 |
66 | MP0005310_abnormal_salivary_gland | 1.41789485 |
67 | MP0004510_myositis | 1.39972582 |
68 | MP0002429_abnormal_blood_cell | 1.39479940 |
69 | MP0002396_abnormal_hematopoietic_system | 1.38910572 |
70 | MP0009697_abnormal_copulation | 1.38393116 |
71 | MP0002822_catalepsy | 1.32417773 |
72 | MP0000703_abnormal_thymus_morphology | 1.32204917 |
73 | MP0001851_eye_inflammation | 1.23296753 |
74 | MP0000858_altered_metastatic_potential | 1.19781509 |
75 | MP0001545_abnormal_hematopoietic_system | 1.19485300 |
76 | MP0005397_hematopoietic_system_phenotyp | 1.19485300 |
77 | MP0009333_abnormal_splenocyte_physiolog | 1.19266846 |
78 | MP0003011_delayed_dark_adaptation | 1.18620623 |
79 | MP0005451_abnormal_body_composition | 1.18114334 |
80 | MP0005647_abnormal_sex_gland | 1.18029693 |
81 | MP0005164_abnormal_response_to | 1.15626652 |
82 | MP0002998_abnormal_bone_remodeling | 1.11151407 |
83 | MP0005166_decreased_susceptibility_to | 1.06976835 |
84 | MP0000598_abnormal_liver_morphology | 1.06504712 |
85 | MP0009643_abnormal_urine_homeostasis | 1.05736105 |
86 | MP0005670_abnormal_white_adipose | 1.02125742 |
87 | MP0003186_abnormal_redox_activity | 1.00944590 |
88 | MP0000569_abnormal_digit_pigmentation | 1.00137843 |
89 | MP0000604_amyloidosis | 0.92816170 |
90 | MP0003705_abnormal_hypodermis_morpholog | 0.92043236 |
91 | MP0003656_abnormal_erythrocyte_physiolo | 0.91712755 |
92 | MP0003787_abnormal_imprinting | 0.89684348 |
93 | MP0002078_abnormal_glucose_homeostasis | 0.88933827 |
94 | MP0006036_abnormal_mitochondrial_physio | 0.88424422 |
95 | MP0002166_altered_tumor_susceptibility | 0.88130764 |
96 | MP0008004_abnormal_stomach_pH | 0.87142297 |
97 | MP0002254_reproductive_system_inflammat | 0.84884511 |
98 | MP0005266_abnormal_metabolism | 0.84684217 |
99 | MP0003878_abnormal_ear_physiology | 0.84476421 |
100 | MP0005377_hearing/vestibular/ear_phenot | 0.84476421 |
101 | MP0003045_fibrosis | 0.83734583 |
102 | MP0002876_abnormal_thyroid_physiology | 0.81250312 |
103 | MP0005376_homeostasis/metabolism_phenot | 0.80859999 |
104 | MP0005636_abnormal_mineral_homeostasis | 0.80844802 |
105 | MP0005535_abnormal_body_temperature | 0.80635105 |
106 | MP0009642_abnormal_blood_homeostasis | 0.79863259 |
107 | MP0003329_amyloid_beta_deposits | 0.78687006 |
108 | MP0009763_increased_sensitivity_to | 0.77722639 |
109 | MP0001986_abnormal_taste_sensitivity | 0.77698689 |
110 | MP0003448_altered_tumor_morphology | 0.76871959 |
111 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76050907 |
112 | MP0005390_skeleton_phenotype | 0.75197667 |
113 | MP0006035_abnormal_mitochondrial_morpho | 0.75041481 |
114 | MP0008872_abnormal_physiological_respon | 0.74001479 |
115 | MP0005075_abnormal_melanosome_morpholog | 0.73787731 |
116 | MP0000015_abnormal_ear_pigmentation | 0.71842655 |
117 | MP0001663_abnormal_digestive_system | 0.71731702 |
118 | MP0000639_abnormal_adrenal_gland | 0.71639628 |
119 | MP0004264_abnormal_extraembryonic_tissu | 0.71281613 |
120 | MP0000343_altered_response_to | 0.71143803 |
121 | MP0009764_decreased_sensitivity_to | 0.70155624 |
122 | MP0009765_abnormal_xenobiotic_induced | 0.70063520 |
123 | MP0002332_abnormal_exercise_endurance | 0.69925451 |
124 | MP0005220_abnormal_exocrine_pancreas | 0.66078749 |
125 | MP0008874_decreased_physiological_sensi | 0.65803840 |
126 | MP0000920_abnormal_myelination | 0.64504045 |
127 | MP0004484_altered_response_of | 0.63242329 |
128 | MP0002971_abnormal_brown_adipose | 0.62456956 |
129 | MP0005334_abnormal_fat_pad | 0.61892706 |
130 | MP0009053_abnormal_anal_canal | 0.60885096 |
131 | MP0005448_abnormal_energy_balance | 0.60006675 |
132 | MP0005058_abnormal_lysosome_morphology | 0.58401479 |
133 | MP0003690_abnormal_glial_cell | 0.57942717 |
134 | MP0003718_maternal_effect | 0.57819091 |
135 | MP0005388_respiratory_system_phenotype | 0.57746318 |
136 | MP0002133_abnormal_respiratory_system | 0.57746318 |
137 | MP0005248_abnormal_Harderian_gland | 0.57319611 |
138 | MP0001853_heart_inflammation | 0.56790475 |
139 | MP0003890_abnormal_embryonic-extraembry | 0.56725651 |
140 | MP0003879_abnormal_hair_cell | 0.56286690 |
141 | MP0004130_abnormal_muscle_cell | 0.56069606 |
142 | MP0005408_hypopigmentation | 0.55907384 |
143 | MP0003953_abnormal_hormone_level | 0.54981303 |
144 | MP0008469_abnormal_protein_level | 0.54276916 |
145 | MP0001661_extended_life_span | 0.54239525 |
146 | MP0000249_abnormal_blood_vessel | 0.54185548 |
147 | MP0004808_abnormal_hematopoietic_stem | 0.53941262 |
148 | MP0009672_abnormal_birth_weight | 0.53252360 |
149 | MP0005084_abnormal_gallbladder_morpholo | 0.51247567 |
150 | MP0003698_abnormal_male_reproductive | 0.50236677 |
151 | MP0001756_abnormal_urination | 0.49467737 |
152 | MP0004043_abnormal_pH_regulation | 0.47448484 |
153 | MP0003638_abnormal_response/metabolism_ | 0.45750564 |
154 | MP0005395_other_phenotype | 0.44691920 |
155 | MP0003075_altered_response_to | 0.44630599 |
156 | MP0008873_increased_physiological_sensi | 0.43696334 |
157 | MP0010234_abnormal_vibrissa_follicle | 0.42442521 |
158 | MP0001929_abnormal_gametogenesis | 0.41363358 |
159 | MP0000579_abnormal_nail_morphology | 0.40961369 |
160 | MP0002161_abnormal_fertility/fecundity | 0.38993306 |
161 | MP0002928_abnormal_bile_duct | 0.38733577 |
162 | MP0002909_abnormal_adrenal_gland | 0.37539817 |
163 | MP0008961_abnormal_basal_metabolism | 0.35986957 |
164 | MP0005666_abnormal_adipose_tissue | 0.35168731 |
165 | MP0002069_abnormal_eating/drinking_beha | 0.34348768 |
166 | MP0003633_abnormal_nervous_system | 0.33144810 |
167 | MP0002837_dystrophic_cardiac_calcinosis | 0.31933039 |
168 | MP0002269_muscular_atrophy | 0.31903434 |
169 | MP0005646_abnormal_pituitary_gland | 0.31486430 |
170 | MP0010368_abnormal_lymphatic_system | 0.31377029 |
171 | MP0001944_abnormal_pancreas_morphology | 0.30491056 |
172 | MP0005167_abnormal_blood-brain_barrier | 0.29865944 |
173 | MP0004133_heterotaxia | 0.29411757 |
174 | MP0002970_abnormal_white_adipose | 0.29123986 |
175 | MP0003632_abnormal_nervous_system | 0.28708383 |
176 | MP0002796_impaired_skin_barrier | 0.28284983 |
177 | MP0003699_abnormal_female_reproductive | 0.27573786 |
178 | MP0004859_abnormal_synaptic_plasticity | 0.26935680 |
179 | MP0005187_abnormal_penis_morphology | 0.26829653 |
180 | MP0003631_nervous_system_phenotype | 0.26713883 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.56484095 |
2 | Intrahepatic cholestasis (HP:0001406) | 7.30428377 |
3 | Deep venous thrombosis (HP:0002625) | 7.05992783 |
4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.00852151 |
5 | Eczematoid dermatitis (HP:0000976) | 6.96852050 |
6 | Hypobetalipoproteinemia (HP:0003563) | 6.51487443 |
7 | Recurrent abscess formation (HP:0002722) | 6.31887915 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 6.31524013 |
9 | Recurrent bacterial skin infections (HP:0005406) | 6.27485242 |
10 | Myositis (HP:0100614) | 6.10872370 |
11 | Orchitis (HP:0100796) | 5.98339066 |
12 | Xanthomatosis (HP:0000991) | 5.91514406 |
13 | Retrobulbar optic neuritis (HP:0100654) | 5.73263322 |
14 | Optic neuritis (HP:0100653) | 5.73263322 |
15 | Abnormality of macrophages (HP:0004311) | 5.45344155 |
16 | Hyperlipoproteinemia (HP:0010980) | 5.28578958 |
17 | Stomatitis (HP:0010280) | 4.98552430 |
18 | Complement deficiency (HP:0004431) | 4.75248735 |
19 | Hyperglycinemia (HP:0002154) | 4.70821678 |
20 | Hypolipoproteinemia (HP:0010981) | 4.69065420 |
21 | Gastrointestinal infarctions (HP:0005244) | 4.63234160 |
22 | Hyperammonemia (HP:0001987) | 4.57526544 |
23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.54913292 |
24 | Epidermoid cyst (HP:0200040) | 4.49512529 |
25 | Abnormality of methionine metabolism (HP:0010901) | 4.47247887 |
26 | Joint hemorrhage (HP:0005261) | 4.46973009 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.45846468 |
28 | Ketosis (HP:0001946) | 4.39613959 |
29 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.29659229 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.22812695 |
31 | Obstructive lung disease (HP:0006536) | 4.19116433 |
32 | Chronic obstructive pulmonary disease (HP:0006510) | 4.19116433 |
33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.17649158 |
34 | Recurrent fungal infections (HP:0002841) | 4.15771958 |
35 | Keratoconjunctivitis sicca (HP:0001097) | 4.15158038 |
36 | Hyperglycinuria (HP:0003108) | 4.11388420 |
37 | Mediastinal lymphadenopathy (HP:0100721) | 4.08852594 |
38 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.06624003 |
39 | Recurrent skin infections (HP:0001581) | 4.06196300 |
40 | Abnormality of the common coagulation pathway (HP:0010990) | 4.03196160 |
41 | Meningitis (HP:0001287) | 4.02888419 |
42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.99528248 |
43 | Abnormality of glycine metabolism (HP:0010895) | 3.99528248 |
44 | Fat malabsorption (HP:0002630) | 3.98306813 |
45 | Hypoalphalipoproteinemia (HP:0003233) | 3.98278058 |
46 | Gingivitis (HP:0000230) | 3.86874569 |
47 | Keratoconjunctivitis (HP:0001096) | 3.83028856 |
48 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.82810830 |
49 | Encephalitis (HP:0002383) | 3.78026605 |
50 | Abnormality of the intrinsic pathway (HP:0010989) | 3.72305868 |
51 | Hypercholesterolemia (HP:0003124) | 3.66027039 |
52 | Conjugated hyperbilirubinemia (HP:0002908) | 3.64051771 |
53 | Urticaria (HP:0001025) | 3.62438239 |
54 | Spontaneous hematomas (HP:0007420) | 3.59784103 |
55 | Hypoglycemic coma (HP:0001325) | 3.54687528 |
56 | Hypochromic anemia (HP:0001931) | 3.49650189 |
57 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.49317098 |
58 | Recurrent cutaneous fungal infections (HP:0011370) | 3.49317098 |
59 | Vasculitis (HP:0002633) | 3.48400986 |
60 | Abnormality of complement system (HP:0005339) | 3.45349326 |
61 | Increased IgE level (HP:0003212) | 3.43506995 |
62 | Peritonitis (HP:0002586) | 3.42718861 |
63 | Episodic fever (HP:0001954) | 3.39572284 |
64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.33025525 |
65 | Chest pain (HP:0100749) | 3.30354505 |
66 | Delayed CNS myelination (HP:0002188) | 3.27824667 |
67 | Prolonged bleeding time (HP:0003010) | 3.27056508 |
68 | Gingival bleeding (HP:0000225) | 3.26054909 |
69 | Cellulitis (HP:0100658) | 3.21602726 |
70 | Hyperbilirubinemia (HP:0002904) | 3.20638820 |
71 | Abnormality of nucleobase metabolism (HP:0010932) | 3.19997657 |
72 | Hypochromic microcytic anemia (HP:0004840) | 3.15285659 |
73 | Ketoacidosis (HP:0001993) | 3.13473149 |
74 | Abnormality of serum amino acid levels (HP:0003112) | 3.11767249 |
75 | Arterial thrombosis (HP:0004420) | 3.07941725 |
76 | Hemoptysis (HP:0002105) | 3.05407406 |
77 | Steatorrhea (HP:0002570) | 2.93579775 |
78 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.88874238 |
79 | Anorexia (HP:0002039) | 2.88816227 |
80 | Pulmonary infiltrates (HP:0002113) | 2.87663233 |
81 | Pulmonary embolism (HP:0002204) | 2.86525781 |
82 | T lymphocytopenia (HP:0005403) | 2.84096754 |
83 | Hepatocellular carcinoma (HP:0001402) | 2.83176042 |
84 | Leukocytosis (HP:0001974) | 2.81520836 |
85 | Gout (HP:0001997) | 2.78916548 |
86 | Skin nodule (HP:0200036) | 2.78512873 |
87 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.78003660 |
88 | Spastic diplegia (HP:0001264) | 2.76032281 |
89 | Abnormality of T cell number (HP:0011839) | 2.75106015 |
90 | Abnormal gallbladder physiology (HP:0012438) | 2.74836434 |
91 | Cholecystitis (HP:0001082) | 2.74836434 |
92 | Epistaxis (HP:0000421) | 2.70708685 |
93 | Metabolic acidosis (HP:0001942) | 2.68196829 |
94 | Spontaneous abortion (HP:0005268) | 2.68190500 |
95 | Abnormality of purine metabolism (HP:0004352) | 2.65166872 |
96 | Status epilepticus (HP:0002133) | 2.60276399 |
97 | Inflammation of the large intestine (HP:0002037) | 2.57093219 |
98 | Lethargy (HP:0001254) | 2.56558019 |
99 | Malnutrition (HP:0004395) | 2.55531084 |
100 | Hypoglycemic seizures (HP:0002173) | 2.53753653 |
101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53544107 |
102 | Osteomyelitis (HP:0002754) | 2.52323429 |
103 | Irritability (HP:0000737) | 2.52260913 |
104 | Microcytic anemia (HP:0001935) | 2.51816056 |
105 | Vascular calcification (HP:0004934) | 2.48959247 |
106 | Abnormality of the lower motor neuron (HP:0002366) | 2.48600755 |
107 | Gangrene (HP:0100758) | 2.47950662 |
108 | Gastrointestinal inflammation (HP:0004386) | 2.47102254 |
109 | Neonatal onset (HP:0003623) | 2.45658211 |
110 | Recurrent viral infections (HP:0004429) | 2.42539048 |
111 | Myocardial infarction (HP:0001658) | 2.42344831 |
112 | Abnormal gallbladder morphology (HP:0012437) | 2.40670277 |
113 | Abnormality of T cells (HP:0002843) | 2.37902582 |
114 | Abnormality of the peritoneum (HP:0002585) | 2.36899292 |
115 | Cholelithiasis (HP:0001081) | 2.36202948 |
116 | Slow saccadic eye movements (HP:0000514) | 2.35521304 |
117 | Sepsis (HP:0100806) | 2.35234368 |
118 | Increased IgM level (HP:0003496) | 2.34956415 |
119 | Abnormality of the pleura (HP:0002103) | 2.29549884 |
120 | Abnormality of the endocardium (HP:0004306) | 2.28910436 |
121 | Dicarboxylic aciduria (HP:0003215) | 2.27893882 |
122 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.27893882 |
123 | Granulocytopenia (HP:0001913) | 2.22752336 |
124 | Cerebral edema (HP:0002181) | 2.21714923 |
125 | Acanthocytosis (HP:0001927) | 2.21180113 |
126 | Vertigo (HP:0002321) | 2.19470595 |
127 | Petechiae (HP:0000967) | 2.18863329 |
128 | Late onset (HP:0003584) | 2.16617230 |
129 | Panhypogammaglobulinemia (HP:0003139) | 2.16044360 |
130 | Lymphopenia (HP:0001888) | 2.13882289 |
131 | Enlarged kidneys (HP:0000105) | 2.13456862 |
132 | Papilledema (HP:0001085) | 2.13426540 |
133 | Pustule (HP:0200039) | 2.11082189 |
134 | Glomerulopathy (HP:0100820) | 2.10838263 |
135 | Acne (HP:0001061) | 2.10791623 |
136 | Cardiovascular calcification (HP:0011915) | 2.10284326 |
137 | Difficulty running (HP:0009046) | 2.09349920 |
138 | Brushfield spots (HP:0001088) | 2.07026191 |
139 | Sensorimotor neuropathy (HP:0007141) | 2.06845142 |
140 | Abnormal platelet volume (HP:0011876) | 2.05383162 |
141 | Pancreatitis (HP:0001733) | 2.03074870 |
142 | Keratitis (HP:0000491) | 2.01543556 |
143 | Mitral stenosis (HP:0001718) | 2.01406391 |
144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00508251 |
145 | Systemic lupus erythematosus (HP:0002725) | 2.00277790 |
146 | Recurrent pneumonia (HP:0006532) | 1.98786200 |
147 | Abnormality of the gallbladder (HP:0005264) | 1.98365988 |
148 | Rickets (HP:0002748) | 1.97445871 |
149 | Abnormality of T cell physiology (HP:0011840) | 1.96521800 |
150 | Hypergammaglobulinemia (HP:0010702) | 1.95829130 |
151 | Colitis (HP:0002583) | 1.95796661 |
152 | Subacute progressive viral hepatitis (HP:0006572) | 1.95431867 |
153 | Glomerulonephritis (HP:0000099) | 1.94773946 |
154 | Premature loss of primary teeth (HP:0006323) | 1.92837498 |
155 | Skin ulcer (HP:0200042) | 1.92690977 |
156 | Purpura (HP:0000979) | 1.92583103 |
157 | Alkalosis (HP:0001948) | 1.92571921 |
158 | Upper motor neuron abnormality (HP:0002127) | 1.91846493 |
159 | Metaphyseal cupping (HP:0003021) | 1.91200439 |
160 | Vomiting (HP:0002013) | 1.90791274 |
161 | Viral hepatitis (HP:0006562) | 1.88661561 |
162 | Hemorrhage of the eye (HP:0011885) | 1.88334713 |
163 | Eosinophilia (HP:0001880) | 1.88220206 |
164 | Esophageal varix (HP:0002040) | 1.87633427 |
165 | Postural instability (HP:0002172) | 1.87501384 |
166 | Hyperventilation (HP:0002883) | 1.86544311 |
167 | Reticulocytosis (HP:0001923) | 1.86168257 |
168 | Thrombophlebitis (HP:0004418) | 1.86085059 |
169 | Chronic otitis media (HP:0000389) | 1.85035479 |
170 | Abnormality of vitamin metabolism (HP:0100508) | 1.83586636 |
171 | Abnormality of the pericardium (HP:0001697) | 1.83345747 |
172 | Confusion (HP:0001289) | 1.82470357 |
173 | Increased purine levels (HP:0004368) | 1.81678038 |
174 | Hyperuricemia (HP:0002149) | 1.81678038 |
175 | Hyperglycemia (HP:0003074) | 1.81521763 |
176 | Poikilocytosis (HP:0004447) | 1.80744342 |
177 | Opisthotonus (HP:0002179) | 1.80523227 |
178 | Polycythemia (HP:0001901) | 1.80153346 |
179 | Menorrhagia (HP:0000132) | 1.78364201 |
180 | Increased serum ferritin (HP:0003281) | 1.78308375 |
181 | Global brain atrophy (HP:0002283) | 1.77593171 |
182 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76909124 |
183 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.76423204 |
184 | Polyneuropathy (HP:0001271) | 1.75645178 |
185 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.74790311 |
186 | Hypophosphatemic rickets (HP:0004912) | 1.74149054 |
187 | Hypermelanotic macule (HP:0001034) | 1.73929514 |
188 | Abnormality of iron homeostasis (HP:0011031) | 1.73733388 |
189 | Tetraplegia (HP:0002445) | 1.73493965 |
190 | Skin rash (HP:0000988) | 1.73323035 |
191 | Nasal polyposis (HP:0100582) | 1.72971002 |
192 | Acute hepatic failure (HP:0006554) | 1.72643460 |
193 | Pseudobulbar signs (HP:0002200) | 1.72515021 |
194 | Amyloidosis (HP:0011034) | 1.72273409 |
195 | IgM deficiency (HP:0002850) | 1.71480469 |
196 | Death in childhood (HP:0003819) | 1.71275965 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.67163172 |
2 | RIPK4 | 5.39591371 |
3 | IRAK4 | 3.25491379 |
4 | SIK1 | 3.18323919 |
5 | MAP4K1 | 3.10474245 |
6 | BLK | 3.08887424 |
7 | MAP2K3 | 3.06266276 |
8 | MAP2K4 | 2.94703847 |
9 | PDK3 | 2.76351170 |
10 | PDK4 | 2.76351170 |
11 | FGFR4 | 2.75835561 |
12 | EPHA4 | 2.73309615 |
13 | TYK2 | 2.72327605 |
14 | ICK | 2.69367566 |
15 | ERN1 | 2.50397693 |
16 | FES | 2.49145434 |
17 | DAPK2 | 2.42275065 |
18 | ERBB4 | 2.37586049 |
19 | TNK2 | 2.35920191 |
20 | INSRR | 2.34187222 |
21 | TAOK3 | 2.26448296 |
22 | PRKD3 | 2.21354283 |
23 | EPHB1 | 2.10431493 |
24 | PRPF4B | 2.08766332 |
25 | PINK1 | 2.08391525 |
26 | AKT3 | 2.01150734 |
27 | MAPK15 | 1.97436033 |
28 | ZAP70 | 1.90037070 |
29 | MAP3K4 | 1.86909360 |
30 | FGR | 1.83584017 |
31 | HCK | 1.69594924 |
32 | PKN2 | 1.68721135 |
33 | JAK3 | 1.66503274 |
34 | FLT3 | 1.66453360 |
35 | MAP3K3 | 1.65422418 |
36 | BTK | 1.64602556 |
37 | MAP3K9 | 1.63906869 |
38 | SYK | 1.57260081 |
39 | STK38 | 1.57108827 |
40 | TXK | 1.49703736 |
41 | PDK2 | 1.47849736 |
42 | NEK1 | 1.46397616 |
43 | MAP3K1 | 1.45370564 |
44 | IKBKE | 1.43387995 |
45 | NTRK3 | 1.39175804 |
46 | MAP3K14 | 1.37210641 |
47 | STK38L | 1.35232091 |
48 | MAPK11 | 1.31676733 |
49 | CDK19 | 1.30959646 |
50 | JAK1 | 1.27492084 |
51 | YES1 | 1.27124527 |
52 | LYN | 1.25953486 |
53 | DAPK1 | 1.25268147 |
54 | MARK2 | 1.25014693 |
55 | GRK6 | 1.24248993 |
56 | LATS1 | 1.22157612 |
57 | LATS2 | 1.21569680 |
58 | MAP2K6 | 1.19261801 |
59 | IRAK2 | 1.15634750 |
60 | SIK3 | 1.15347389 |
61 | FRK | 1.09255581 |
62 | IRAK1 | 1.06618688 |
63 | SIK2 | 1.06506757 |
64 | TBK1 | 1.06498906 |
65 | TYRO3 | 1.05405553 |
66 | PRKCZ | 1.03626923 |
67 | PRKCG | 1.02519196 |
68 | MST1R | 1.01696194 |
69 | LCK | 0.99604066 |
70 | MATK | 0.95370332 |
71 | DYRK1B | 0.93331174 |
72 | MAP3K6 | 0.91761209 |
73 | PIK3CG | 0.91391339 |
74 | MARK3 | 0.91363902 |
75 | CSF1R | 0.91146487 |
76 | BMPR2 | 0.90675096 |
77 | PTK6 | 0.90017297 |
78 | CAMKK1 | 0.88759403 |
79 | PRKAA1 | 0.87340413 |
80 | ABL2 | 0.85869196 |
81 | TESK1 | 0.85742624 |
82 | MAP3K10 | 0.84549835 |
83 | FGFR2 | 0.84438064 |
84 | ITK | 0.83798077 |
85 | TAOK2 | 0.83461093 |
86 | KIT | 0.83031391 |
87 | PRKD2 | 0.82546208 |
88 | SGK3 | 0.81130574 |
89 | MAP3K2 | 0.79481880 |
90 | MAP3K11 | 0.75836641 |
91 | JAK2 | 0.73321422 |
92 | FYN | 0.72249287 |
93 | LRRK2 | 0.71902715 |
94 | PDK1 | 0.71886529 |
95 | TEC | 0.71771386 |
96 | PDPK1 | 0.71661502 |
97 | PRKACG | 0.71537944 |
98 | RAF1 | 0.70672359 |
99 | CDK6 | 0.70420336 |
100 | KSR2 | 0.70350224 |
101 | PNCK | 0.70219727 |
102 | MAP3K7 | 0.69846604 |
103 | KSR1 | 0.68689129 |
104 | SGK2 | 0.68470161 |
105 | GRK5 | 0.67065516 |
106 | EPHA2 | 0.66934197 |
107 | CDK12 | 0.66419364 |
108 | NTRK1 | 0.66408878 |
109 | FGFR3 | 0.64774491 |
110 | PRKAA2 | 0.64755230 |
111 | PAK6 | 0.63603826 |
112 | WNK1 | 0.63087099 |
113 | STK10 | 0.61712390 |
114 | CAMK2G | 0.60020420 |
115 | GRK1 | 0.59443412 |
116 | GSK3A | 0.59165181 |
117 | MTOR | 0.57852978 |
118 | TRIB3 | 0.57725383 |
119 | ERBB2 | 0.57512579 |
120 | NTRK2 | 0.57506055 |
121 | TESK2 | 0.54048523 |
122 | PTK2 | 0.53229634 |
123 | IKBKB | 0.52981380 |
124 | TTK | 0.52048246 |
125 | MINK1 | 0.51321384 |
126 | MAP2K7 | 0.49183499 |
127 | SMG1 | 0.49132399 |
128 | PRKCQ | 0.48018469 |
129 | SGK223 | 0.47644341 |
130 | SGK494 | 0.47644341 |
131 | CSNK1E | 0.47472755 |
132 | MAPK4 | 0.46295603 |
133 | RIPK1 | 0.45794633 |
134 | MAPK7 | 0.45305041 |
135 | BMX | 0.45257216 |
136 | RPS6KA3 | 0.44076729 |
137 | MET | 0.42927036 |
138 | CDC42BPA | 0.42751730 |
139 | EPHA3 | 0.42727536 |
140 | STK11 | 0.41870623 |
141 | RPS6KB1 | 0.40738690 |
142 | PRKCH | 0.40735660 |
143 | PTK2B | 0.40625606 |
144 | CAMK4 | 0.39173128 |
145 | CSK | 0.38604273 |
146 | PRKG2 | 0.37871235 |
147 | RET | 0.35655919 |
148 | PIM1 | 0.35068105 |
149 | CDK4 | 0.35050329 |
150 | RPS6KC1 | 0.34865752 |
151 | RPS6KL1 | 0.34865752 |
152 | HIPK2 | 0.34449262 |
153 | MAP3K5 | 0.33942530 |
154 | CAMKK2 | 0.33025071 |
155 | TGFBR2 | 0.32822624 |
156 | TAOK1 | 0.32209565 |
157 | PRKCA | 0.29684942 |
158 | MAP3K13 | 0.28571592 |
159 | ALK | 0.24545838 |
160 | BRAF | 0.23522228 |
161 | MAPK12 | 0.22625144 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.41926024 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.70985189 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.70217707 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.34601771 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.25987451 |
6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 3.10729961 |
7 | Leishmaniasis_Homo sapiens_hsa05140 | 3.03339911 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.63730230 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.63089930 |
10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.53867020 |
11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49821176 |
12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.44586080 |
13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.38124294 |
14 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.33257016 |
15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.31430352 |
16 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.28570878 |
17 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.23962605 |
18 | Tuberculosis_Homo sapiens_hsa05152 | 2.23240015 |
19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.21670936 |
20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12182840 |
21 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.10141381 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.09820049 |
23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09550251 |
24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94291524 |
25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.93628861 |
26 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.91602972 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.90061274 |
28 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89014108 |
29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85741400 |
30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.84491870 |
31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.81993118 |
32 | Malaria_Homo sapiens_hsa05144 | 1.80765446 |
33 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.79641257 |
34 | Allograft rejection_Homo sapiens_hsa05330 | 1.78631055 |
35 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.77863488 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.76478339 |
37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.76317515 |
38 | Histidine metabolism_Homo sapiens_hsa00340 | 1.74721557 |
39 | Measles_Homo sapiens_hsa05162 | 1.73080151 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.69032860 |
41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.67618108 |
42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66185874 |
43 | Bile secretion_Homo sapiens_hsa04976 | 1.63832934 |
44 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61987668 |
45 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61710733 |
46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60796647 |
47 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60123739 |
48 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59536968 |
49 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.58812692 |
50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.57113972 |
51 | Legionellosis_Homo sapiens_hsa05134 | 1.55257669 |
52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.54875356 |
53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.53471045 |
54 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.52723652 |
55 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49329991 |
56 | Influenza A_Homo sapiens_hsa05164 | 1.46334687 |
57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44566196 |
58 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38944242 |
59 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.38768724 |
60 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37922434 |
61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37787213 |
62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.37578736 |
63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37537377 |
64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.37091368 |
65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.36487820 |
66 | Phagosome_Homo sapiens_hsa04145 | 1.36379227 |
67 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.35842172 |
68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.32849047 |
69 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27321914 |
70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.26966308 |
71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.26866656 |
72 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26368655 |
73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.22636621 |
74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21917028 |
75 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21224838 |
76 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20087162 |
77 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18933793 |
78 | Platelet activation_Homo sapiens_hsa04611 | 1.16940218 |
79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16649176 |
80 | ABC transporters_Homo sapiens_hsa02010 | 1.16234559 |
81 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.16082769 |
82 | Viral myocarditis_Homo sapiens_hsa05416 | 1.15667395 |
83 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15648217 |
84 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15494966 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.13410419 |
86 | Hepatitis B_Homo sapiens_hsa05161 | 1.13390055 |
87 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.12021618 |
88 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08938104 |
89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.08442084 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 1.07477141 |
91 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05038361 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.01657717 |
93 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98270302 |
94 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.97576957 |
95 | Pertussis_Homo sapiens_hsa05133 | 0.97239131 |
96 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95837648 |
97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94778674 |
98 | Salmonella infection_Homo sapiens_hsa05132 | 0.94498125 |
99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93471762 |
100 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92649831 |
101 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90733838 |
102 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90191281 |
103 | Endocytosis_Homo sapiens_hsa04144 | 0.87710807 |
104 | Shigellosis_Homo sapiens_hsa05131 | 0.86535685 |
105 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.86434244 |
106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85394999 |
107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83812157 |
108 | Apoptosis_Homo sapiens_hsa04210 | 0.81870755 |
109 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81626599 |
110 | Lysine degradation_Homo sapiens_hsa00310 | 0.80764436 |
111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80511108 |
112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80233812 |
113 | Long-term potentiation_Homo sapiens_hsa04720 | 0.79245196 |
114 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78086971 |
115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76690464 |
116 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.75642453 |
117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.75557084 |
118 | Sulfur relay system_Homo sapiens_hsa04122 | 0.75200445 |
119 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74009631 |
120 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73841983 |
121 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73240326 |
122 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.71438964 |
123 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71141647 |
124 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70457634 |
125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70267927 |
126 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.69377493 |
127 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68542631 |
128 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.67778036 |
129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66734860 |
130 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.65699534 |
131 | Amoebiasis_Homo sapiens_hsa05146 | 0.63606625 |
132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62913482 |
133 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61114854 |
134 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59738384 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59585618 |
136 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.59043490 |
137 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58674670 |
138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58361909 |
139 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57950280 |
140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.57038452 |
141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56896904 |
142 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.56367379 |
143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56017162 |
144 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.54107766 |
145 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51469229 |
146 | Glioma_Homo sapiens_hsa05214 | 0.51447254 |
147 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50432195 |
148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.49945928 |
149 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.49658321 |
150 | Asthma_Homo sapiens_hsa05310 | 0.49535918 |
151 | Colorectal cancer_Homo sapiens_hsa05210 | 0.49336260 |
152 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49041024 |
153 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48172893 |
154 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.46963825 |
155 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43690061 |
156 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42198613 |
157 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.40248202 |
158 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39638678 |
159 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33998851 |
160 | Prion diseases_Homo sapiens_hsa05020 | 0.32852854 |
161 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.32648488 |
162 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29064866 |
163 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28376620 |
164 | Insulin resistance_Homo sapiens_hsa04931 | 0.20290408 |
165 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.14458578 |
166 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.09696905 |
167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.01600188 |
168 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | -0.1876856 |
169 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1867632 |
170 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1848379 |
171 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | -0.1754769 |
172 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1645522 |
173 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.1448860 |
174 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1385290 |
175 | Nicotine addiction_Homo sapiens_hsa05033 | -0.1218252 |
176 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.1019018 |
177 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0951918 |
178 | Amphetamine addiction_Homo sapiens_hsa05031 | -0.0888232 |
179 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0875914 |
180 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0837744 |
181 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0826909 |
182 | Insulin secretion_Homo sapiens_hsa04911 | -0.0614809 |
183 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0477752 |
184 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0456471 |
185 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.0327330 |
186 | GABAergic synapse_Homo sapiens_hsa04727 | -0.0173036 |
187 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0161536 |
188 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0136880 |